Jarkko Ojala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jarkko Ojala has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Mika Kapanen
Unit of Radiotherapy, Department of Oncology, Tampere University Hospital, Tampere, Finland
7 shared publicationsJani Keyriläinen
University of Turku
5 shared publications- Mari Partanen
Unit of Radiotherapy, Department of Oncology, Tampere University Hospital, Tampere, Finland
3 shared publications Petri Sipilä
Radiation and Nuclear Safety Authority (STUK), Jokiniemenkuja 1, FI-01370 Vantaa
3 shared publications- Jarkko Niemelä
MVision AI, Helsinki, Finland
2 shared publications - Klemens Zink
University Medical Center Giessen-Marburg, Department of Radiotherapy and Radiooncology, Baldingerstrasse, Marburg, 35043, GERMANY
2 shared publications
Latest Publications
- Open Access
- 4 April 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (8) , 084003
Validation of HDR brachytherapy doses in the treatment of keloid scars using the egs_brachy Monte Carlo application
Objective . Radiotherapy is a well-known alternative in the treatment of keloid scars to reduce the recurrence of scars. The purpose of this study was to investigate the feasibility and accuracy of dose delivered from a high-dose-rate (HDR) afterloaders in keloid scar brachytherapy using Monte Carlo (MC) simulations and measurements. Approach . Treatment doses and central axis dose profiles were measured using radiophotoluminescence dosimeters and radiochromic films, respectively, with two HDR afterloaders, both using an Ir-192 source, in a phantom made of solid water and polycarbonate sheets. The nominal treatment dose calculated by the AAPM Task Group No. 43 (TG-43) dose model was set to 8.5 Gy at a distance of 0.5 cm laterally from the middle of the source line located in a plastic applicator simulating a 15 cm long surgically removed scar treatment with 30 equally spaced (0.5 cm) source positions. The dose profiles were measured at three different distances from the applicator and the absolute doses at four points at different distances. MC simulations were performed using the egs_brachy, which is based on EGSnrc code system. Main results . The measured and simulated dose profiles match well, especially at 10.0 mm (difference Significance . Simulated and measured dose levels at a depth of 0.5 cm showed that the nominal treatment dose can be achieved with the utilized setup. The measurement results of the absolute dose agree well with the corresponding simulation results.
- 4 April 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (8) , 084003
Open AccessValidation of HDR brachytherapy doses in the treatment of keloid scars using the egs_brachy Monte Carlo application
Objective . Radiotherapy is a well-known alternative in the treatment of keloid scars to reduce the recurrence of scars. The purpose of this study was to investigate the feasibility and accuracy of dose delivered from a high-dose-rate (HDR) afterloaders in keloid scar brachytherapy using Monte Carlo (MC) simulations and measurements. Approach . Treatment doses and central axis dose profiles were measured using radiophotoluminescence dosimeters and radiochromic films, respectively, with two HDR afterloaders, both using an Ir-192 source, in a phantom made of solid water and polycarbonate sheets. The nominal treatment dose calculated by the AAPM Task Group No. 43 (TG-43) dose model was set to 8.5 Gy at a distance of 0.5 cm laterally from the middle of the source line located in a plastic applicator simulating a 15 cm long surgically removed scar treatment with 30 equally spaced (0.5 cm) source positions. The dose profiles were measured at three different distances from the applicator and the absolute doses at four points at different distances. MC simulations were performed using the egs_brachy, which is based on EGSnrc code system. Main results . The measured and simulated dose profiles match well, especially at 10.0 mm (difference Significance . Simulated and measured dose levels at a depth of 0.5 cm showed that the nominal treatment dose can be achieved with the utilized setup. The measurement results of the absolute dose agree well with the corresponding simulation results.
- Open Access
- 1 November 2021
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 212, 106457
Profeel—An open source dosimetry data visualization and analysis software
- 1 November 2021
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 212, 106457
Open AccessProfeel—An open source dosimetry data visualization and analysis software
- 1 October 2021
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (11) , 1419-1424
Properties of IBA Razor Nano Chamber in small-field radiation therapy using 6 MV FF, 6 MV FFF, and 10 MV FFF photon beams
Small megavoltage photon fields are increasingly used in modern radiotherapy techniques such as stereotactic radiotherapy. Therefore, it is important to study the reliability of dosimetry in the sm...
- 1 October 2021
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 60 (11) , 1419-1424
Properties of IBA Razor Nano Chamber in small-field radiation therapy using 6 MV FF, 6 MV FFF, and 10 MV FFF photon beams
Small megavoltage photon fields are increasingly used in modern radiotherapy techniques such as stereotactic radiotherapy. Therefore, it is important to study the reliability of dosimetry in the sm...
- 1 May 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (3) , 035019
Dose-area product ratio in external small-beam radiotherapy: beam shape, size and energy dependencies in clinical photon beams
In small-field radiotherapy (RT), a significant challenge is to define the amount of radiation dose absorbed in the patient where the quality of the beam has to be measured with high accuracy. The properties of a proposed new beam quality specifier, namely the dose-area-product ratio at 20 and 10 cm depths in water or DAPR 20,10 , were studied to yield more information on its feasibility over the conventional quality specifier tissue-phantom ratio or TPR 20,10 . The DAPR 20,10 may be measured with a large-area ionization chamber (LAC) instead of small volume chambers or semi-conductors where detector, beam and water phantom positioning and beam perturbations introduce uncertainties. The effects of beam shape, size and energy on the DAPR 20,10 were studied and it was shown that the DAPR 20,10 increases with increasing beam energy similarly to TPR 20,10 but in contrast exhibits a small beam size and shape dependence. The beam profile outside the beam limiting devices has been shown to have a large contribution to the DAPR 20,10 . There is potential in large area chambers to be used in DAPR measurement and its use in dosimetry of small-beam RT for beam quality measurements.
- 1 May 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (3) , 035019
Dose-area product ratio in external small-beam radiotherapy: beam shape, size and energy dependencies in clinical photon beams
In small-field radiotherapy (RT), a significant challenge is to define the amount of radiation dose absorbed in the patient where the quality of the beam has to be measured with high accuracy. The properties of a proposed new beam quality specifier, namely the dose-area-product ratio at 20 and 10 cm depths in water or DAPR 20,10 , were studied to yield more information on its feasibility over the conventional quality specifier tissue-phantom ratio or TPR 20,10 . The DAPR 20,10 may be measured with a large-area ionization chamber (LAC) instead of small volume chambers or semi-conductors where detector, beam and water phantom positioning and beam perturbations introduce uncertainties. The effects of beam shape, size and energy on the DAPR 20,10 were studied and it was shown that the DAPR 20,10 increases with increasing beam energy similarly to TPR 20,10 but in contrast exhibits a small beam size and shape dependence. The beam profile outside the beam limiting devices has been shown to have a large contribution to the DAPR 20,10 . There is potential in large area chambers to be used in DAPR measurement and its use in dosimetry of small-beam RT for beam quality measurements.
- 7 May 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (9) , 095011
Determination of consensus k Q values for megavoltage photon beams for the update of IAEA TRS-398
The IAEA is currently coordinating a multi-year project to update the TRS-398 Code of Practice for the dosimetry of external beam radiotherapy based on standards of absorbed dose to water. One major aspect of the project is the determination of new beam quality correction factors, k Q , for megavoltage photon beams consistent with developments in radiotherapy dosimetry and technology since the publication of TRS-398 in 2000. Specifically, all values must be based on, or consistent with, the key data of ICRU Report 90. Data sets obtained from Monte Carlo (MC) calculations by advanced users and measurements at primary standards laboratories have been compiled for 23 cylindrical ionization chamber types, consisting of 725 MC-calculated and 179 experimental data points. These have been used to derive consensus k Q values as a function of the beam quality index TPR 20,10 with a combined standard uncertainty of 0.6%. Mean values of MC-derived chamber-specific f c h factors for cylindrical and plane-parallel chamber types in 60 Co beams have also been obtained with an estimated uncertainty of 0.4%.
- 7 May 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (9) , 095011
Determination of consensus k Q values for megavoltage photon beams for the update of IAEA TRS-398
The IAEA is currently coordinating a multi-year project to update the TRS-398 Code of Practice for the dosimetry of external beam radiotherapy based on standards of absorbed dose to water. One major aspect of the project is the determination of new beam quality correction factors, k Q , for megavoltage photon beams consistent with developments in radiotherapy dosimetry and technology since the publication of TRS-398 in 2000. Specifically, all values must be based on, or consistent with, the key data of ICRU Report 90. Data sets obtained from Monte Carlo (MC) calculations by advanced users and measurements at primary standards laboratories have been compiled for 23 cylindrical ionization chamber types, consisting of 725 MC-calculated and 179 experimental data points. These have been used to derive consensus k Q values as a function of the beam quality index TPR 20,10 with a combined standard uncertainty of 0.6%. Mean values of MC-derived chamber-specific f c h factors for cylindrical and plane-parallel chamber types in 60 Co beams have also been obtained with an estimated uncertainty of 0.4%.
- Open Access
- 26 March 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (7) , 075003
Calculated beam quality correction factors for ionization chambers in MV photon beams
The beam quality correction factor, , which corrects for the difference in the ionization chamber response between the reference and clinical beam quality, is an integral part of radiation therapy dosimetry. The uncertainty of is one of the most significant sources of uncertainty in the dose determination. To improve the accuracy of available data, four partners calculated factors for 10 ionization chamber models in linear accelerator beams with accelerator voltages ranging from 6 MV to 25 MV, including flattening-filter-free (FFF) beams. The software used in the calculations were EGSnrc and PENELOPE, and the ICRU report 90 cross section data for water and graphite were included in the simulations. Volume averaging correction factors were calculated to correct for the dose averaging in the chamber cavities. A comparison calculation between partners showed a good agreement, as did comparison with literature. The values from TRS-398 were higher than our values for each chamber where data was available. The values for the FFF beams did not follow the same , relation as beams with flattening filter (values for 10 MV FFF beams were below fits made to other data on average by 0.3%), although our FFF sources were only for Varian linacs.
- 26 March 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (7) , 075003
Open AccessCalculated beam quality correction factors for ionization chambers in MV photon beams
The beam quality correction factor, , which corrects for the difference in the ionization chamber response between the reference and clinical beam quality, is an integral part of radiation therapy dosimetry. The uncertainty of is one of the most significant sources of uncertainty in the dose determination. To improve the accuracy of available data, four partners calculated factors for 10 ionization chamber models in linear accelerator beams with accelerator voltages ranging from 6 MV to 25 MV, including flattening-filter-free (FFF) beams. The software used in the calculations were EGSnrc and PENELOPE, and the ICRU report 90 cross section data for water and graphite were included in the simulations. Volume averaging correction factors were calculated to correct for the dose averaging in the chamber cavities. A comparison calculation between partners showed a good agreement, as did comparison with literature. The values from TRS-398 were higher than our values for each chamber where data was available. The values for the FFF beams did not follow the same , relation as beams with flattening filter (values for 10 MV FFF beams were below fits made to other data on average by 0.3%), although our FFF sources were only for Varian linacs.
- 1 November 2018
- Published by Elsevier in Physica Medica
- Vol. 55, 82-87
Monte Carlo investigation on the effect of air gap under bolus in post-mastectomy radiotherapy
- 1 November 2018
- Published by Elsevier in Physica Medica
- Vol. 55, 82-87
Monte Carlo investigation on the effect of air gap under bolus in post-mastectomy radiotherapy
- Open Access
- 3 April 2018
- Published by Springer Nature in Radiation Oncology
- Vol. 13 (1) , 60
Dosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes?
For a given prescribed dose of radiotherapy, with the successive generations of dose calculation algorithms, more monitor units (MUs) are generally needed. This is due to the implementation of successive improvements in dose calculation: better heterogeneity correction and more accurate estimation of secondary electron transport contribution. More recently, there is the possibility to report the dose-to-medium, physically more accurate compared to the dose-to-water as the reference one. This last point is a recent concern and the main focus of this study. In this paper, we propose steps for a general analysis procedure to estimate the dosimetric alterations, and the potential clinical changes, between a reference algorithm and a new one. This includes dosimetric parameters, gamma index, radiobiology indices based on equivalent uniform dose concept and statistics with bootstrap simulation. Finally, we provide a general recommendation on the clinical use of new algorithms regarding the dose prescription or dose limits to the organs at risks. The dosimetrical and radiobiological data showed a significant effect, which might exceed 5–10%, of the calculation method on the dose the distribution and clinical outcomes for lung cancer patients. Wilcoxon signed rank paired comparisons indicated that the delivered dose in MUs was significantly increased (> 2%) using more advanced dose calculation methods as compared to the reference one. This paper illustrates and explains the use of dosimetrical, radiobiologcal and statistical tests for dosimetric comparisons in radiotherapy. The change of dose calculation algorithm may induce a dosimetric shift, which has to be evaluated by the physicists and the oncologists. This includes the impact on tumor control and on the risk of toxicity based on normal tissue dose constraints. In fact, the alteration in dose distribution makes it hard to keep exactly the same tumor control probability along with the same normal tissue complication probability.
- 3 April 2018
- Published by Springer Nature in Radiation Oncology
- Vol. 13 (1) , 60
Open AccessDosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes?
For a given prescribed dose of radiotherapy, with the successive generations of dose calculation algorithms, more monitor units (MUs) are generally needed. This is due to the implementation of successive improvements in dose calculation: better heterogeneity correction and more accurate estimation of secondary electron transport contribution. More recently, there is the possibility to report the dose-to-medium, physically more accurate compared to the dose-to-water as the reference one. This last point is a recent concern and the main focus of this study. In this paper, we propose steps for a general analysis procedure to estimate the dosimetric alterations, and the potential clinical changes, between a reference algorithm and a new one. This includes dosimetric parameters, gamma index, radiobiology indices based on equivalent uniform dose concept and statistics with bootstrap simulation. Finally, we provide a general recommendation on the clinical use of new algorithms regarding the dose prescription or dose limits to the organs at risks. The dosimetrical and radiobiological data showed a significant effect, which might exceed 5–10%, of the calculation method on the dose the distribution and clinical outcomes for lung cancer patients. Wilcoxon signed rank paired comparisons indicated that the delivered dose in MUs was significantly increased (> 2%) using more advanced dose calculation methods as compared to the reference one. This paper illustrates and explains the use of dosimetrical, radiobiologcal and statistical tests for dosimetric comparisons in radiotherapy. The change of dose calculation algorithm may induce a dosimetric shift, which has to be evaluated by the physicists and the oncologists. This includes the impact on tumor control and on the risk of toxicity based on normal tissue dose constraints. In fact, the alteration in dose distribution makes it hard to keep exactly the same tumor control probability along with the same normal tissue complication probability.
- 22 May 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (12) , 4870-4883
Measurement and properties of the dose–area product ratio in external small-beam radiotherapy
In small-beam radiation therapy (RT) the measurement of the beam quality parameter, i.e. the tissue–phantom ratio or TPR 20,10 , using a conventional point detector is a challenge. To obtain reliable results, one has to consider potential sources of error, including volume averaging and adjustment of the point detector into the narrow beam. To overcome these challenges, a different type of beam quality parameter in small beams was studied, namely the dose–area product ratio, or DAPR 20,10 . With this method, the measurement of a dose–area product (DAP) using a large-area plane-parallel chamber (LAC) eliminates the uncertainties in detector positioning and volume averaging that are present when using a point detector. In this study, the properties of the DAPR 20,10 of a cone-collimated 6 MV photon beam were investigated using Monte Carlo (MC) calculations and the obtained values were compared to measurements obtained using two LAC detectors, PTW Type 34073 and PTW Type 34070. In addition, the possibility of determining the DAP using EBT3 film and a Razor diode detector was studied. The determination of the DAPR 20,10 value was found to be feasible in external small-beam radiotherapy using cone-collimated beams with diameters from 4–40 mm, based on the results of the two LACs, the MC calculations and the Razor diode. The measurements indicated a constant DAPR 20,10 value for fields 20–40 mm in diameter, with a maximum relative change of 0.6%, but an increase of 7.0% for fields from 20–4 mm in diameter for the PTW Type 34070 chamber. Simulations and measurements showed an increase of DAPR 20,10 with increasing LAC size or dose integral area for the studied 4–40 mm cone-collimated 6 MV photon beams. This has the consequence that there should be a reference to the size of the used LAC active area or the DAP integration area with the reported DAPR 20,10 value.
- 22 May 2017
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 62 (12) , 4870-4883
Measurement and properties of the dose–area product ratio in external small-beam radiotherapy
In small-beam radiation therapy (RT) the measurement of the beam quality parameter, i.e. the tissue–phantom ratio or TPR 20,10 , using a conventional point detector is a challenge. To obtain reliable results, one has to consider potential sources of error, including volume averaging and adjustment of the point detector into the narrow beam. To overcome these challenges, a different type of beam quality parameter in small beams was studied, namely the dose–area product ratio, or DAPR 20,10 . With this method, the measurement of a dose–area product (DAP) using a large-area plane-parallel chamber (LAC) eliminates the uncertainties in detector positioning and volume averaging that are present when using a point detector. In this study, the properties of the DAPR 20,10 of a cone-collimated 6 MV photon beam were investigated using Monte Carlo (MC) calculations and the obtained values were compared to measurements obtained using two LAC detectors, PTW Type 34073 and PTW Type 34070. In addition, the possibility of determining the DAP using EBT3 film and a Razor diode detector was studied. The determination of the DAPR 20,10 value was found to be feasible in external small-beam radiotherapy using cone-collimated beams with diameters from 4–40 mm, based on the results of the two LACs, the MC calculations and the Razor diode. The measurements indicated a constant DAPR 20,10 value for fields 20–40 mm in diameter, with a maximum relative change of 0.6%, but an increase of 7.0% for fields from 20–4 mm in diameter for the PTW Type 34070 chamber. Simulations and measurements showed an increase of DAPR 20,10 with increasing LAC size or dose integral area for the studied 4–40 mm cone-collimated 6 MV photon beams. This has the consequence that there should be a reference to the size of the used LAC active area or the DAP integration area with the reported DAPR 20,10 value.
- 2 March 2017
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 56 (6) , 891-893
Comparison of two Monte Carlo-based codes for small-field dose calculations in external beam radiotherapy
Small treatment fields are increasingly used with modern radiotherapy (RT) techniques, such as in stereotactic radiotherapy (SRT) [1]. The use of small fields enables more precise treatment, but wi...
- 2 March 2017
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 56 (6) , 891-893
Comparison of two Monte Carlo-based codes for small-field dose calculations in external beam radiotherapy
Small treatment fields are increasingly used with modern radiotherapy (RT) techniques, such as in stereotactic radiotherapy (SRT) [1]. The use of small fields enables more precise treatment, but wi...